Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib Phase 2 in Crohn's Disease
NCT00615199Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of tofacitinib oral solution in Crohn's disease, sponsored by Pfizer. Started Jan 2008; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00615199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615199.